The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Targeted and controlled anticancer drug delivery and release with magnetoelectric nanoparticles
Open accessAbstract
It is a challenge to eradicate tumor cells while sparing normal cells. We used magnetoelectric nanoparticles (MENs) to control drug delivery and release. The physics is due to electric-field interactions (i) between MENs and a drug and (ii) between drug-loaded MENs and cells. MENs distinguish cancer cells from normal cells through the membrane’s electric properties; cancer cells have a significantly smaller threshold field to induce electroporation. In vitro and in vivo studies (nude mice with SKOV-3 xenografts) showed that (i) drug (paclitaxel (PTX)) could be attached to MENs (30-nm CoFe 2 O 4@BaTiO 3 nanostructures) through surface functionalization to avoid its premature release, (ii) drug-loaded MENs could be delivered into cancer cells via application of a d.c. field (~100 Oe), and (iii) the drug could be released off MENs on demand via application of an a.c. field (~50 Oe, 100 Hz). The cell lysate content was measured with scanning probe microscopy and spectrophotometry. MENs and control ferromagnetic and polymer nanoparticles conjugated with HER2-neu antibodies, all loaded with PTX were weekly administrated intravenously. Only the mice treated with PTX-loaded MENs (15/200 μg) in a field for three months were completely cured, as confirmed through infrared imaging and post-euthanasia histology studies via energy-dispersive spectroscopy and immunohistochemistry.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multiferroic and magnetoelectric materials
Eerenstein, W., Mathur, N. D., & Scott, J. F. (2006) · Nature · doi:10.1038/nature05023 · Cited by 8,002
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
Kantoff, P. W., Higano, C. S., Shore, N. D., Berger, E. R., Small, E. J., Penson, D. F., Redfern, C. H., Ferrari, A. C., Dreicer, R., Sims, R. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001294 · Cited by 5,572
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Magnetic control of ferroelectric polarization
Kimura, T., Goto, T., Shintani, H., Ishizaka, K., Arima, T., & Tokura, Y. (2003) · Nature · doi:10.1038/nature02018 · Cited by 4,718
PLGA-based nanoparticles: An overview of biomedical applications
Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Le Breton, A., & Préat, V. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.043 · Cited by 3,806
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,039
Danhier, F., Feron, O., & Préat, V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.027 · Cited by 2,800
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Armstrong, D. K., Bundy, B., Wenzel, L., Huang, H. Q., Baergen, R., Lele, S., Copeland, L. J., Walker, J. L., & Burger, R. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052985 · Cited by 2,625
Maeda, H. (2001) · Advances in Enzyme Regulation · doi:10.1016/s0065-2571(00)00013-3 · Cited by 2,495
PEGylation, successful approach to drug delivery
Veronese, F. M., & Pasut, G. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03575-0 · Cited by 2,339
Nanoparticle and targeted systems for cancer therapy
Brannon-Peppas, L., & Blanchette, J. O. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.02.014 · Cited by 2,334
Magnetic nanoparticles for drug delivery
Arruebo, M., Fernández-Pacheco, R., Ibarra, M. R., & Santamaría, J. (2007) · Nano Today · doi:10.1016/s1748-0132(07)70084-1 · Cited by 1,613
Nanoparticle Delivery of Cancer Drugs
Wang, A. Z., Langer, R., & Farokhzad, O. C. (2012) · Annual Review of Medicine · doi:10.1146/annurev-med-040210-162544 · Cited by 1,561
Prabhakar, U., Maeda, H., Jain, R. K., Sevick-Muraca, E. M., Zamboni, W., Farokhzad, O. C., Barry, S. T., Gabizon, A., Grodzinski, P., & Blakey, D. C. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4561 · Cited by 1,485
Multistage nanoparticle delivery system for deep penetration into tumor tissue
Wong, C., Stylianopoulos, T., Cui, J., Martin, J., Chauhan, V. P., Jiang, W., Popović, Z., Jain, R. K., Bawendi, M. G., & Fukumura, D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018382108 · Cited by 1,062
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.006 · Cited by 956
Magnetic nanoparticles for gene and drug delivery
Dobson (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s1608 · Cited by 755
Three-dimensional real-time in vivo magnetic particle imaging
Weizenecker, J., Gleich, B., Rahmer, J., Dahnke, H., & Borgert, J. (2009) · Physics in Medicine and Biology · doi:10.1088/0031-9155/54/5/l01 · Cited by 651
Membrane potential and cancer progression
Yang, M., & Brackenbury, W. J. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00185 · Cited by 614
Remotely Triggerable Drug Delivery Systems
Timko, B. P., Dvir, T., & Kohane, D. S. (2010) · Advanced Materials · doi:10.1002/adma.201002072 · Cited by 614
The role of HER2 in cancer therapy and targeted drug delivery
Tai, W., Mahato, R., & Cheng, K. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.04.009 · Cited by 555
Particle shape enhances specificity of antibody-displaying nanoparticles
Barua, S., Yoo, J.-W., Kolhar, P., Wakankar, A., Gokarn, Y. R., & Mitragotri, S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1216893110 · Cited by 523
Remotely Triggered Liposome Release by Near-Infrared Light Absorption via Hollow Gold Nanoshells
Wu, G., Mikhailovsky, A., Khant, H. A., Fu, C., Chiu, W., & Zasadzinski, J. A. (2008) · Journal of the American Chemical Society · doi:10.1021/ja802656d · Cited by 500
Photoswitchable Nanoparticles for Triggered Tissue Penetration and Drug Delivery
Tong, R., Hemmati, H. D., Langer, R., & Kohane, D. S. (2012) · Journal of the American Chemical Society · doi:10.1021/ja211888a · Cited by 477
Interface-induced room-temperature multiferroicity in BaTiO3
Valencia, S., Crassous, A., Bocher, L., Garcia, V., Moya, X., Cherifi, R. O., Deranlot, C., Bouzéhouane, K., Fusil, S., Zobelli, A., et al. (2011) · Nature Materials · doi:10.1038/nmat3098 · Cited by 399
A Magnetically Triggered Composite Membrane for On-Demand Drug Delivery
Hoare, T., Santamaria, J., Goya, G. F., Irusta, S., Lin, D., Lau, S., Padera, R., Langer, R., & Kohane, D. S. (2009) · Nano Letters · doi:10.1021/nl9018935 · Cited by 362
Kim, D.-W., Kim, S.-Y., Kim, H.-K., Kim, S.-W., Shin, S. W., Kim, J. S., Park, K., Lee, M. Y., & Heo, D. S. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm374 · Cited by 356
Cardiac rehabilitation outcomes following a 6-week program of PCI and CABG Patients
Jelinek, H. F., Huang, Z. Q., Khandoker, A. H., Chang, D., & Kiat, H. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00302 · Cited by 339
Targeted Drug Delivery in Cancer Therapy
Vasir, J. K., & Labhasetwar, V. (2005) · Technology in Cancer Research & Treatment · doi:10.1177/153303460500400405 · Cited by 327
Batrakova, E. V., Gendelman, H. E., & Kabanov, A. V. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.559457 · Cited by 323
Kim, D. K., Zhang, Y., Kehr, J., Klason, T., Bjelke, B., & Muhammed, M. (2001) · Journal of Magnetism and Magnetic Materials · doi:10.1016/s0304-8853(00)01255-5 · Cited by 321
Magnetic guidance of drug-carrying microspheres
Senyei, A., Widder, K., & Czerlinski, G. (1978) · Journal of Applied Physics · doi:10.1063/1.325219 · Cited by 318
Passive versus Active Tumor Targeting Using RGD- and NGR-Modified Polymeric Nanomedicines
Kunjachan, S., Pola, R., Gremse, F., Theek, B., Ehling, J., Moeckel, D., Hermanns-Sachweh, B., Pechar, M., Ulbrich, K., Hennink, W. E., et al. (2014) · Nano Letters · doi:10.1021/nl404391r · Cited by 317
Polymer conjugates with anticancer activity
Putnam, D., & Kopeček, J. (1995) · Advances in Polymer Science · doi:10.1007/3540587888_14 · Cited by 315
Nair, M., Guduru, R., Liang, P., Hong, J., Sagar, V., & Khizroev, S. (2013) · Nature Communications · doi:10.1038/ncomms2717 · Cited by 287
Self-citationRemotely Triggered Release from Magnetic Nanoparticles
Derfus, A. M., von Maltzahn, G., Harris, T. J., Duza, T., Vecchio, K. S., Ruoslahti, E., & Bhatia, S. N. (2007) · Advanced Materials · doi:10.1002/adma.200700091 · Cited by 282
Targeted drug delivery for cancer therapy: the other side of antibodies
Firer, M. A., & Gellerman, G. (2012) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-5-70 · Cited by 269
Biodegradable, polymeric nanoparticle delivery systems for cancer therapy
Pridgen, E. M., Langer, R., & Farokhzad, O. C. (2007) · Nanomedicine · doi:10.2217/17435889.2.5.669 · Cited by 249
Lim, E., Huh, Y., Yang, J., Lee, K., Suh, J., & Haam, S. (2011) · Advanced Materials · doi:10.1002/adma.201100351 · Cited by 220
In vivo human time-exposure study of orally dosed commercial silver nanoparticles
Munger, M. A., Radwański, P., Hadlock, G. C., Stoddard, G., Shaaban, A. M., Falconer, J. L., Grainger, D. W., & Deering‐Rice, C. E. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.06.010 · Cited by 212
Brain tumor-targeted drug delivery strategies
Wei, X., Chen, X., Ying, M., & Lu, W. (2014) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2014.03.001 · Cited by 205
Monoclonal Antibodies in Cancer Therapy: 25 Years of Progress
Oldham, R. K., & Dillman, R. O. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.7438 · Cited by 204
Synthesis and characterization of novel CoFe2O4–BaTiO3 multiferroic core–shell-type nanostructures
Corral-Flores, V., Bueno-Baqués, D., & Ziolo, R. F. (2010) · Acta Materialia · doi:10.1016/j.actamat.2009.09.054 · Cited by 191
Modeling Particle Shape-Dependent Dynamics in Nanomedicine
Shah, S., Liu, Y., Hu, W., & Gao, J. (2011) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2011.3536 · Cited by 189
Zhang, W., Gilstrap, K., Wu, L., K. C., R. B., Moss, M. A., Wang, Q., Lu, X., & He, X. (2010) · ACS Nano · doi:10.1021/nn101617n · Cited by 179
Guduru, R., Liang, P., Runowicz, C., Nair, M., Atluri, V., & Khizroev, S. (2013) · Scientific Reports · doi:10.1038/srep02953 · Cited by 178
Self-citationMagnetoelectric ‘spin’ on stimulating the brain.
Guduru, R., Liang, P., Hong, J., Rodzinski, A., Hadjikhani, A., Horstmyer, J., Levister, E., & Khizroev, S. (2015) · Nanomedicine · doi:10.2217/nnm.15.52 · Cited by 171
Self-citationA Bacterial Protein Enhances the Release and Efficacy of Liposomal Cancer Drugs
Cheong, I., Huang, X., Bettegowda, C., Diaz, L. A., Kinzler, K. W., Zhou, S., & Vogelstein, B. (2006) · Science · doi:10.1126/science.1130651 · Cited by 168
Magneto-electric nano-particles for non-invasive brain stimulation.
Yue, K., Guduru, R., Hong, J., Liang, P., Nair, M., & Khizroev, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044040 · Cited by 161
Self-citationControlled biodegradability of polymers — a key to drug delivery systems
Kopec̆ek, J. (1984) · Biomaterials · doi:10.1016/0142-9612(84)90062-0 · Cited by 155
Critical Determinants in PLGA/PLA Nanoparticle-Mediated Gene Expression
Prabha, S., & Labhasetwar, V. D. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016250.56402.99 · Cited by 150
Li, X., Zhao, Q., & Qiu, L. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.06.006 · Cited by 149
Modelling the Transport of Nanoparticles under Blood Flow using an Agent-based Approach
Fullstone, G., Wood, J., Holcombe, M., & Battaglia, G. (2015) · Scientific Reports · doi:10.1038/srep10649 · Cited by 142
The Future Is Now: Chimeric Antigen Receptors as New Targeted Therapies for Childhood Cancer
Lee, D. W., Barrett, D. M., Mackall, C. L., Orentas, R. J., & Grupp, S. A. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1920 · Cited by 128
Cellular potentials of normal and cancerous fibroblasts and hepatocytes.
Binggeli, R. L., & Cameron, I. L. (1980) · PubMed · Cited by 86
Disposition of Ultrasound Sensitive Polymeric Drug Carrier in a Rat Hepatocellular Carcinoma Model
Cochran, M. C., Eisenbrey, J. R., Soulen, M. C., Schultz, S. M., Ouma, R. O., White, S. B., Furth, E. E., & Wheatley, M. A. (2011) · Academic Radiology · doi:10.1016/j.acra.2011.06.013 · Cited by 62
Guduru, R., & Khizroev, S. (2013) · Particle & Particle Systems Characterization · doi:10.1002/ppsc.201300238 · Cited by 59
Self-citationMolecular electroporation and the transduction of oligoarginines
Cahill, K. E. (2009) · Physical Biology · doi:10.1088/1478-3975/7/1/016001 · Cited by 28
The membrane potential of primary ovarian tumor cells in vitro and its dependence on the cell cycle.
Redmann, K., Müller, E., Tanneberger, S., et al. (1972) · PubMed · Cited by 15
Cited by
Magnetic nanoparticles for environmental and biomedical applications: a review
Mohammed, L., Gomaa, H. G., Ragab, D., & Zhu, J. (2017) · Particuology · doi:10.1016/j.partic.2016.06.001 · Cited by 682
Piezoelectric materials as stimulatory biomedical materials and scaffolds for bone repair
Tandon, B., Blaker, J. J., & Cartmell, S. H. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.04.026 · Cited by 420
Muhamad, N., Plengsuriyakarn, T., & Na-Bangchang, K. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s165210 · Cited by 410
Drug delivery systems for programmed and on-demand release
Davoodi, P., Lee, L. Y., Xu, Q., Sunil, V., Sun, Y., Soh, S., & Wang, C.-H. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.002 · Cited by 353
Shafei, A., El-Bakly, W., Sobhy, A., Wagdy, O., Reda, A., Aboelenin, O., Marzouk, A., El Habak, K., Mostafa, R., Ali, M. A., et al. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.09.059 · Cited by 318
Metadata
- Authors
- Rodzinski, A., Guduru, R., Liang, P., Hadjikhani, A., Stewart, T., Stimphil, E., Runowicz, C., Cote, R., Altman, N., Datar, R., & Khizroev, S.
- Venue
- Scientific Reports
- Published
- 2016-02-15
- Volume
- 6
- Issue
- 1
- Pages
- 20867-20867
- ISSN
- 2045-2322 (ISSN-L)
- OpenAlex
- W2283047478
- Cited by
- 271
- References
- 59
- FWCI
- 13.03
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.